Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fosfomycin + imipenem for MRSA infective endocarditis
2008-008683-28Phase 4Completed
- Sponsor
- Fundació Clínic per a la Recerca Biomèdica
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of fosfomycin and imipenem in endocarditis (IE) (2 arms), sponsored by Fundació Clínic per a la Recerca Biomèdica. Started Mar 2009; status: completed.
02
Drugs
fosfomycinimipenem
03
Conditions
endocarditis (IE)
Beyond the preview
Go deeper on 2008-008683-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008683-28.